Physician profile
Stephen V Moss
NPI 1457455446
$916.26
in general payments reported to CMS, 2019-2025
9 companies · $46.61 in 2025
The $46.61 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.29 · 2020: $37.50 · 2021: $91.66 · 2022: $265 · 2023: $376 · 2025: $46.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $340.94 | 2022-2023 | Affinity, Puraply |
| Smith+Nephew, INC. | $128.61 | 2022 | |
| Horizon Therapeutics Plc | $117.24 | 2023 | Krystexxa |
| Merck Sharp & Dohme LLC | $99.29 | 2019 | |
| Grt US Holding, INC. | $91.66 | 2021 | |
| Bard Peripheral Vascular, INC. | $46.61 | 2025 | Fluency Endovascular Stent Graft |
| Amniox Medical, INC. | $37.50 | 2020 | |
| Convatec INC. | $32.24 | 2023 | |
| Triad Life Sciences INC. | $22.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.